Investing in SNDL? Read Our Focused Overview.

By Tamara Parker • Friday, October 20 10:48 • Permanent Link

Mid-cap Health Care company SNDL has logged a -1.0% change today on a trading volume of 564,301. The average volume for the stock is 4,904,371.

SNDL Inc. engages in the production, distribution, and sale of cannabis products in Canada. Based in Calgary, Canada the company has 2,607 full time employees and a market cap of $384,237,504.

The company is now trading -54.62% away from its average analyst target price of $3.25 per share. The 1 analysts following the stock have set target prices ranging from $3.25 to $3.25, and on average give SNDL a rating of buy.

Over the last 12 months SNDL shares have declined by -32.0%, which represents a difference of -46.0% when compared to the S&P 500. The stock's 52 week high is $3.36 per share and its 52 week low is $1.25. Based on SNDL's average net margin growth of 1.3% over the last 3 years, its core business remains strong and the stock price may recover in the long term.

Date Reported	Total Revenue ($ k)	Net Profit ($ k)	Net Margins (%)	YoY Growth (%)
2022-04-28	56,128	-230,182	-409	-3.81
2021-03-18	60,918	-239,944	-394	7.51
2020-03-31	63,562	-271,629	-426

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.